Lung deposition of salbutamol in healthy human subjects from the MAGhaler dry powder inhaler

Respiratory Medicine

Volumn 96, Issue 12, 2002, Pages 1026-1032

  Newman, S ^a   Malik, S ^a   Hirst, P ^a   Pitcairn, G ^a   Heide, A ^b   Pabst, J ^b   Dinkelaker, A ^b   Fleischer, W ^c  

^a PHARMACEUTICAL PROFILES LTD   (United Kingdom)

^b GGU GmbH   (Germany)

^c MUNDIPHARMA GMBH   (Germany)

Author keywords

Bronchodilators; Dry powder inhaler; Gamma scintigraphy

Indexed keywords

SALBUTAMOL; TECHNETIUM 99M;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DISTRIBUTION; DRUG FORMULATION; FEMALE; FLOW RATE; HUMAN; HUMAN EXPERIMENT; INHALATION; ISOTOPE LABELING; MALE; METERED DOSE INHALER; NORMAL HUMAN; POWDER INHALER; PRIORITY JOURNAL; REPRODUCIBILITY; SCINTISCANNING; TABLET; TECHNIQUE;

EID: 0036891846     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2002.1387     Document Type: Article

References (23)

1. Partridge MR, Woodcock AA, Sheffer AL, Wanner A, Rubinfeld A. Chlorofluorocarbon-free inhalers: are we ready for the change? Eur Respir J 1998; 11: 1006-1008.
2. Clark AR. Medical aerosol inhalers: past, present and future. Aerosol Sci Technol 1995; 22: 374-391.
3. Wetterlin K. Turbuhaler: a new powder inhaler for administration of drugs to the airways. Pharm Res 1988; 5: 506-508.
4. Brindley A, Sumby BS, Smith IJ, Haywood PA, Grant AC. Design, manufacture and dose consistency of the Serevent Diskus Inhaler. Pharm Tech Eur 1995; 9: 14-22.
5. Ashurst I, Malton A, Prime D, Sumby B. Latest advances in the development of dry powder inhalers. Pharm Sci Technol Today 2000; 3: 246-256.
6. Newman SP. Scintigraphic assessment of pulmonary delivery systems. Pharm Tech 1998; 22: 78-94.
7. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6 (Suppl 16): 5-40.
8. Pitcairn GR, Lim J, Hollingworth A, Newman SP. Scintigraphic assessment of drug delivery from the Ultrahaler dry powder inhaler. J Aerosol Med 1997; 10: 295-306.
9. 99mTc. J Aerosol Med 1996; 9 (Suppl 1): S27-S36.
10. Newman SP. Characteristics of radiolabelled versus unlabelled formulations. J Aerosol Med 1996; 9 (Suppl 1): S37-S47.
11. Newman SP, Hirst PH, Pitcairn GR, Clark AR. Understanding regional lung deposition in gamma scintigraphy. In: Dalby RN, Byron PR, Farr SJ (eds). Respiratory Drug Delivery VI. Buffalo Grove: Interpharm Press, 1998; 9-15.
12. Pitcairn GR, Newman SP. Tissue attenuation corrections in gamma scintigraphy. J Aerosol Med 1997; 3: 187-198.
13. Smith IJ. The challenge of reformulation. J Aerosol Med 1995; 8: S19-S27.
14. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998; 12: 1346-1353.
15. Timsina MP, Martin GP, Marriott C, Ganderton D, Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm 1994; 101: 1-13.
16. Pitcairn GR, Lankinen T, Seppälä O-P, Newman SP. Pulmonary drug delivery from the Taifun dry powder inhaler is relatively independent of the patient's inspiratory effort. J Aerosol Med 2000; 13: 97-104.
17. Borgström L, Bondesson E, Morén F, Trofast E, Newman SP. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. Eur Respir J 1994; 7: 69-73.
18. Newman SP, Pitcairn GR, Hirst PH, Bacon RE, O'Keefe E, Reiners M, Hermann R. Scintigraphic comparison of budesonide deposition from two dry powder inhalers. Eur Respir J 2000; 16: 178-183.
19. Pitcairn GR, Lunghetti G, Ventura P, Newman SP. A comparison of the lung deposition of salbutamol inhaled from a new dry powder inhaler, at two inhaled flow rates. Int J Pharm 1994; 102: 11-18.
20. Newman SP, Hollingworth A, Clark AR. Effect of different modes of inhalation on drug delivery from a dry powder inhaler. Int J Pharm 1994; 102: 127-132.
21. Warren SJ, Taylor G. Effect of inhalation flow profiles on the deposition of radiolabelled BDP from a novel dry powder inhaler (Clickhaler), a conventional metered dose inhaler and MDI plus spacer. In: Dalby RN, Byron PR, Farr SJ (eds). Respiratory Drug Delivery VI. Buffalo Grove: Interpharm Press, 1998: 453-455.
22. Hill M, Vaughan L, Dolovich M. Dose targeting for dry powder inhalers. In: Dalby RN, Byron PR, Farr SJ (eds). Respiratory Drug Delivery V. Buffalo Grove: Interpharm Press, 1996: 197-208.
23. Pedersen S. How to use a Rotahaler. Arch Dis Childhood 1986; 61: 11-14.